Avanir Pharmaceuticals, Idec deal

AVN’s Xenerex Biosciences subsidiary acquired IDPH’s ownership interest in U.S. Patent No. 5,958,765 covering a process for generating human monoclonal antibodies using human spleen cells grafted into...